טוען...
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade
AIMS: Nitric oxide (NO) deficiency contributes to chronic kidney disease progression. Nebivolol, a beta adrenergic receptor antagonist, may enhance endogenous NO. Here, we investigated whether nebivolol attenuates hypertension and renal injury after 5/6 ablation/ infarction (A/I). Efficacy was compa...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412179/ https://ncbi.nlm.nih.gov/pubmed/22727796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2012.06.005 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|